Rejection and function and chronic allograft dysfunction

Area of Science:

• Nephrology
• Transplantation Immunology
• Biomarker Research

Background:

• Chronic allograft dysfunction is a significant challenge post-renal transplantation, despite reduced early acute rejection rates.
• Factors like organ quality, ischemia/reperfusion injury, and acute rejection impact renal structure, leading to fibrosis and atrophy.
• The prognostic significance of subclinical acute rejection and borderline changes remains debated, especially when excluding specific complicating factors.

Purpose of the Study:

• To evaluate the utility of protocol biopsies in managing renal allograft dysfunction.
• To address the limitations of current biomarkers for assessing renal function and immunosuppression.
• To identify optimal strategies for patients at risk of late acute rejection.

Main Methods:

• Review of current literature on renal transplantation outcomes and biomarkers.
• Analysis of the role of protocol biopsies in detecting subclinical changes.
• Discussion of the unreliability of serum creatinine and immunosuppressant trough levels.

Main Results:

• Serum creatinine is an insensitive marker for glomerular filtration rate and renal damage.
• Immunosuppressant trough level monitoring is unreliable for guiding drug dosing or exposure control.
• Protocol biopsies may offer valuable insights into subclinical rejection and fibrosis.

Conclusions:

• Current biomarkers (serum creatinine, trough levels) are insufficient for accurate assessment of renal function and immunosuppression.
• Protocol biopsies are recommended for high-risk patients to detect potential late acute rejection.
• Further research into sophisticated biomarkers is needed to guide immunosuppression effectively.